Akero Therapeutics

AKRO

54.6500.00% ( 0.000 )

Delisted: Dec 8, 16:00:00 (EDT)

Q3 FY2025 Earnings

Financial report interval: 2025.06.30 - 2025.09.30

Overview: Akero Therapeutics(AKRO) the EBIT is -90.24 M (-10.44%);the EPS is -0.995 (+5%).

Actual

YoY

Estimate

YoY

Vs estimate

YoY

EBIT

-0.09B10.44%

----

----

EPS

-0.99465.00%

----

----

Revenue

ActualEstimateUnit: USD

Quarterly

EBIT

ActualEstimateUnit: USD

Quarterly

Net income

ActualEstimateUnit: USD

Quarterly

EPS

ActualEstimateUnit: USD

Quarterly